RT Journal Article
SR Electronic
T1 Research Protocol for a Randomised Controlled Trial Comparing the Outcome of the 3D-Printed Patient-Specific-Instrument Assisted Lapidus Fusion vs Conventional Lapidus Fusion for Surgical Correction of Hallux Valgus Deformity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.05.23296589
DO 10.1101/2023.10.05.23296589
A1 Ling, Samuel Ka-Kin
A1 Wei, Rachel Xiaoyu
A1 Chui, Elvis Chun-Sing
A1 Chong, Boon Hor
A1 Ong, Michael Tim-Yun
A1 Lui, Pauline Po-Yee
A1 Yung, Patrick Shu-Hang
YR 2023
UL http://medrxiv.org/content/early/2023/10/05/2023.10.05.23296589.abstract
AB Introduction Hallux valgus (HV) affects up to 30% of the population. Lapidus surgery with 1st tarsal-metatarsal joint arthrodesis is one of the most common surgical options for HV. Despite its popularity, the current procedure is not without complications. This investigation will be the world’s first Lapidus arthrodesis surgery utilising patient-specific instruments (PSI) as an assistive tool. We hypothesise that the PSI will enhance surgical precision, accelerate fusion rates, decrease non-unions, and reduce the need to use bone grafts.Methods and analysis This is a single-blinded, parallel-group, randomised controlled trial comparing the outcome of the 3D-Printed PSI Assisted Lapidus Fusion (n=27) vs Conventional Lapidus Fusion (n=27) for HV deformity. Both groups will receive an identical postoperative rehabilitation of protected weight bearing and splinting. Outcomes will include foot function scores, radiological alignment and arthrodesis site assessment with X-ray and High-Resolution Peripheral Quantitative-Computed Tomography, and foot pressure analysis.StrengthsThis will be the world’s first randomised control trial utilising PSI for hallux valgus surgery.Surgeries are done by a team of experienced foot and ankle surgeons.LimitationsA single-centre study with a follow-up of only 1 year. However, the authors believe that traditional Lapidus surgery has known term results, and the chief hypothetical benefit of PSI-assisted surgery is faster bony fusion and less surgical complications, which will be evident within 1 year.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinicalTrials.gov Identifier: NCT05602844Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Joint CUHK-NTEC CREC Ref 2020.633-T has granted ethics approval for this proposed study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.